Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.

Ke ZhuWen DengHui DengXiaoqiang LiuGongxian Wang Bin Fu

Published in: PPAR research (2021)

We constructed and validated a novel PPAR signature, which showed the excellent performance in predicting prognosis and chemotherapy sensitivity of BLCA patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
insulin resistance
stem cells
prognostic factors
squamous cell carcinoma
wastewater treatment